| dc.contributor.author |
Singhvi, Gautam |
|
| dc.contributor.author |
Taliyan, Rajeev |
|
| dc.date.accessioned |
2025-11-10T10:54:35Z |
|
| dc.date.available |
2025-11-10T10:54:35Z |
|
| dc.date.issued |
2025-11 |
|
| dc.identifier.uri |
https://link.springer.com/article/10.1186/s43088-025-00706-x |
|
| dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/20004 |
|
| dc.description.abstract |
Cancer is one of the leading causes of death globally, with the reported numbers rising every year. Although the medical fraternity has made considerable progress in early detection and treatment interventions, the numbers are expected to increase drastically by 2040. The most prevalent cause of mortality in people with diverse cancer types is likely multidrug resistance (MDR). As per recent reports, there have been increased incidences of cancer being reported globally, with projections of low-Human Development Index (HDI) countries being affected more in the near future. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
Springer |
en_US |
| dc.subject |
Pharmacy |
en_US |
| dc.subject |
Cancer mortality |
en_US |
| dc.subject |
Multidrug resistance (MDR) |
en_US |
| dc.subject |
Global cancer incidence |
en_US |
| dc.subject |
Low-HDI countries impact |
en_US |
| dc.title |
The role of diet and nutraceuticals in the amelioration of multidrug resistance amongst cancer patients |
en_US |
| dc.type |
Article |
en_US |